The abstract is read at the publisher; the summary is JClub's.
TSPO-PET binding in 10 people with frontotemporal dementia is linked to higher CD68+ phagocytic microglia burden, with regional association β = 8.66 (P < 0.001).
- Why it matters: TSPO-PET is used as a neuroinflammation proxy in FTD, but it was unclear whether its elevated signal reflects microglial, astrocytic, or vascular pathology.
- What they did: The study paired ante mortem [11 C]PK11195 TSPO-PET with quantitative post-mortem tissue in 10 FTD cases (5 FTLD-tau, 5 FTLD-TDP) and 5 matched controls, using CD68 immunohistochemistry across 17 regions and multiplex staining for TSPO with IBA1, GFAP, and CD31.
- The result: Only the CD68-TSPO co-localised fraction tracked PET signal (β = +0.0041, P = 0.015; P FDR = 0.062), and single-cell reconstruction showed CD68+ IBA1+ microglia had more absolute TSPO and were larger, supporting TSPO-PET as a microglial-burden biomarker across FTLD-tau and FTLD-TDP.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.